These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 11779082

  • 1. Angiogenesis inhibition in solid tumors.
    Rosen LS.
    Cancer J; 2001; 7 Suppl 3():S120-8. PubMed ID: 11779082
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 3. Role of angiogenesis inhibitors in acute myeloid leukemia.
    Fiedler W, Staib P, Kuse R, Dührsen U, Flasshove M, Cavalli F, Hossfeld DK, Berdel WE.
    Cancer J; 2001; 7 Suppl 3():S129-33. PubMed ID: 11779083
    [Abstract] [Full Text] [Related]

  • 4. SU6668, a multitargeted angiogenesis inhibitor.
    Hoekman K.
    Cancer J; 2001; 7 Suppl 3():S134-8. PubMed ID: 11779084
    [Abstract] [Full Text] [Related]

  • 5. Endothelial survival factors as targets for antineoplastic therapy.
    Reinmuth N, Stoeltzing O, Liu W, Ahmad SA, Jung YD, Fan F, Parikh A, Ellis LM.
    Cancer J; 2001; 7 Suppl 3():S109-19. PubMed ID: 11779081
    [Abstract] [Full Text] [Related]

  • 6. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ.
    Clin Cancer Res; 2006 Nov 01; 12(21):6573-84. PubMed ID: 17085673
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 10. Advances in the use of angiogenesis inhibitors in cancer.
    Pinedo HM.
    Cancer J; 2001 Apr 01; 7 Suppl 3():S107-8. PubMed ID: 11779080
    [No Abstract] [Full Text] [Related]

  • 11. Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells.
    Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, Weber KJ, Huber PE.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1220-32. PubMed ID: 15519795
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats.
    Roman CD, Choy H, Nanney L, Riordan C, Parman K, Johnson D, Beauchamp RD.
    J Surg Res; 2002 Jun 01; 105(1):43-7. PubMed ID: 12069500
    [Abstract] [Full Text] [Related]

  • 13. Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.
    Mendel DB, Laird AD, Smolich BD, Blake RA, Liang C, Hannah AL, Shaheen RM, Ellis LM, Weitman S, Shawver LK, Cherrington JM.
    Anticancer Drug Des; 2000 Feb 01; 15(1):29-41. PubMed ID: 10888034
    [Abstract] [Full Text] [Related]

  • 14. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 15. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
    Lee L, Sharma S, Morgan B, Allegrini P, Schnell C, Brueggen J, Cozens R, Horsfield M, Guenther C, Steward WP, Drevs J, Lebwohl D, Wood J, McSheehy PM.
    Cancer Chemother Pharmacol; 2006 Jun 15; 57(6):761-71. PubMed ID: 16172907
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases.
    Giles FJ, Cooper MA, Silverman L, Karp JE, Lancet JE, Zangari M, Shami PJ, Khan KD, Hannah AL, Cherrington JM, Thomas DA, Garcia-Manero G, Albitar M, Kantarjian HM, Stopeck AT.
    Cancer; 2003 Apr 15; 97(8):1920-8. PubMed ID: 12673719
    [Abstract] [Full Text] [Related]

  • 17. Angiogenesis inhibitors in the treatment of lung cancer.
    Sun S, Schiller JH.
    Crit Rev Oncol Hematol; 2007 May 15; 62(2):93-104. PubMed ID: 17306557
    [Abstract] [Full Text] [Related]

  • 18. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Langer CJ, Natale RB.
    Semin Oncol; 2005 Dec 15; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
    [Abstract] [Full Text] [Related]

  • 19. Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptors.
    Tandle A, Libutti SK.
    Clin Adv Hematol Oncol; 2003 Jan 15; 1(1):41-8. PubMed ID: 16227959
    [Abstract] [Full Text] [Related]

  • 20. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.
    Polverino A, Coxon A, Starnes C, Diaz Z, DeMelfi T, Wang L, Bready J, Estrada J, Cattley R, Kaufman S, Chen D, Gan Y, Kumar G, Meyer J, Neervannan S, Alva G, Talvenheimo J, Montestruque S, Tasker A, Patel V, Radinsky R, Kendall R.
    Cancer Res; 2006 Sep 01; 66(17):8715-21. PubMed ID: 16951187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.